Microvascular disease confers additional risk to COVID-19 infection-Reference-Cited by-同舟云学术

Microvascular disease confers additional risk to COVID-19 infection

Published:2020-11 Issue: Volume:144 Page:109999
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Bale Bradley Field,Doneen Amy Lynn,Vigerust David John

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. B. Mullen. ACC CLINICAL BULLETIN COVID-19 Clinical Guidance For the Cardiovascular Care Team. 20202020.

2. First line of defense: innate cell-mediated control of pulmonary aspergillosis;Espinosa;Front Microbiol,2016

3. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies;Conti;J Biol Regul Homeost Agents,2020

4. Host responses from innate to adaptive immunity after vaccination: molecular and cellular events;Kang;Mol Cells,2009

5. Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease);Sechtem;Cardiovasc Res,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus Disease 2019 Histology and Histopathology;Reference Module in Social Sciences;2024

2. Novel mechanism of the COVID-19 associated coagulopathy (CAC) and vascular thromboembolism;npj Viruses;2023-10-18

3. The relationship between peripheral immune response and disease severity in SARS‐CoV‐2‐infected subjects: A cross‐sectional study;Immunology;2022-03-02

4. The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients;Open Medicine;2022-01-01

5. Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection;Advanced Drug Delivery Reviews;2021-02